Zoetis Starts New Site Construction in Suzhou
publication date: Apr 29, 2018
Zoetis Inc., a multi-national animal health company, started constructing its 43,000 square meters of new facility in Suzhou. The new site will be used for vaccine manufacturing operations and laboratory space, specifically for manufacturing of viral and bacterial vaccines, including pilot scale manufacturing for the development of new vaccine products. Zoetis expects to complete construction and Good Manufacturing Practices certification by the Chinese Ministry of Agriculture by 2021. The new facility will create 100 new R&D manufacturing positions. More details....
Stock Symbol: (NYSE: ZTS)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.